Chemical Structure : CCG-222740
CAS No.: 1922098-69-8
Catalog No.: PC-35330Not For Human Use, Lab Use Only.
CCG-222740 (CCG222740) is a pharmacological inhibitor of MRTF/SRF signalling, shows greater inhibitory effect on MRTF/SRF target genes than MRTF-A inhibitor CCG-203971, with IC50 of 5 uM in fibroblast-mediated collagen contraction assay.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $248 | In stock | |
10 mg | $398 | In stock | |
25 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CCG-222740 (CCG222740) is a pharmacological inhibitor of MRTF/SRF signalling, shows greater inhibitory effect on MRTF/SRF target genes than MRTF-A inhibitor CCG-203971, with IC50 of 5 uM in fibroblast-mediated collagen contraction assay.
CCG-222740 is a more potent inhibitor of alpha-smooth muscle actin protein expression than CCG-203971.
CCG-222740 prevents scar tissue formation in a preclinical model of fibrosis; effectively kills BRAFi-resistant melanoma cells.
M.Wt | 444.863 | |
Formula | C23H19ClF2N2O3 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
N-(4-chlorophenyl)-5,5-difluoro-1-(3-(furan-2-yl)benzoyl)piperidine-3-carboxamide |
1. Hutchings KM, et al. Bioorg Med Chem Lett. 2017 Apr 15;27(8):1744-1749.
2. Yu-Wai-Man C, et al. Sci Rep. 2017 Mar 31;7(1):518.
3. Sean A. Misek, et al. Abstract 5895: Targeting RhoA-regulated gene transcription in drug-resistant melanoma. AACR 2018.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright